These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 2786217)

  • 1. Interleukin-1 induces a shock-like state in rabbits: synergism with tumor necrosis factor and the effect of ibuprofen.
    Dinarello CA; Okusawa S; Gelfand JA
    Prog Clin Biol Res; 1989; 299():203-15. PubMed ID: 2786217
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin-1 induces a shock-like state in rabbits: synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.
    Dinarello CA; Okusawa S; Gelfand JA
    Prog Clin Biol Res; 1989; 286():243-63. PubMed ID: 2494673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor.
    Bertini R; Bianchi M; Ghezzi P
    J Exp Med; 1988 May; 167(5):1708-12. PubMed ID: 3259257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.
    Okusawa S; Gelfand JA; Ikejima T; Connolly RJ; Dinarello CA
    J Clin Invest; 1988 Apr; 81(4):1162-72. PubMed ID: 3258319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-induced bowel necrosis: the role of platelet-activating factor.
    Hsueh W; Sun XM
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():363-6. PubMed ID: 2526499
    [No Abstract]   [Full Text] [Related]  

  • 6. Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha-induced changes in circulating numbers of neutrophils and lymphocytes.
    Ulich TR; del Castillo J; Keys M; Granger GA; Ni RX
    J Immunol; 1987 Nov; 139(10):3406-15. PubMed ID: 3316383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional regulation of the biological effects of TNF-alpha by the soluble type I and type II TNF receptors.
    Hale KK; Smith CG; Baker SL; Vanderslice RW; Squires CH; Gleason TM; Tucker KK; Kohno T; Russell DA
    Cytokine; 1995 Jan; 7(1):26-38. PubMed ID: 7749064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary TNF-binding protein (TNF soluble receptor) protects mice against the lethal effect of TNF and endotoxic shock.
    Bertini R; Delgado R; Faggioni R; Gascon MP; Ythier A; Ghezzi P
    Eur Cytokine Netw; 1993; 4(1):39-42. PubMed ID: 8387827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxic effects of cytokines in vivo.
    Remick DG; Kunkel SL
    Lab Invest; 1989 Mar; 60(3):317-9. PubMed ID: 2648064
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential effects of IL-1 beta and ibuprofen after endotoxic challenge in mice.
    Mansilla-Roselló A; Ferrón-Orihuela JA; Ruiz-Cabello F; Garrote-Lara D; Fernández-Mondéjar E; Delgado-Carrasco ML
    J Surg Res; 1997 Feb; 67(2):199-204. PubMed ID: 9073568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effect of 5-fluorouracil and recombinant tumor necrosis factor against human gastric carcinoma cell lines.
    Li Y; Ito S; Cheng W; Ishii Y
    Anticancer Res; 1996; 16(4A):1771-4. PubMed ID: 8712699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitization and desensitization to lethal effects of tumor necrosis factor and IL-1.
    Wallach D; Holtmann H; Engelmann H; Nophar Y
    J Immunol; 1988 May; 140(9):2994-9. PubMed ID: 3258889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the functional activities of two different preparations of human recombinant tumor necrosis factor alpha.
    Zeman K; Paleolog EM; Tchórzewski H; Szymańska B
    Arch Immunol Ther Exp (Warsz); 1993; 41(2):159-64. PubMed ID: 8239921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a locus on distal mouse chromosome 12 that controls resistance to tumor necrosis factor-induced lethal shock.
    Libert C; Wielockx B; Hammond GL; Brouckaert P; Fiers W; Elliott RW
    Genomics; 1999 Feb; 55(3):284-9. PubMed ID: 10049582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tumor necrosis factor in normal subjects.
    N Engl J Med; 1990 Nov; 323(19):1350-2. PubMed ID: 2215625
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of tumor necrosis factor on the production of interleukin-1 by macrophages.
    Hoffman MK
    Lymphokine Res; 1986; 5(4):255-60. PubMed ID: 3491252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mutein of tumor necrosis factor alpha (F4614) with reduced hypotensive effect.
    Shikama H; Miyata K; Sakae N; Mitsuishi Y; Nishimura K; Kuroda K; Kato M
    J Interferon Cytokine Res; 1995 Aug; 15(8):677-84. PubMed ID: 8528939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ibuprofen does not affect levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptor types I and II in Gabonese children with uncomplicated Plasmodium falciparum malaria.
    Matsiegui PB; Missinou MA; Issifou S; Necek M; Mavoungou E
    Eur Cytokine Netw; 2007 Dec; 18(4):201-5. PubMed ID: 17964975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor alpha.
    Halin C; Gafner V; Villani ME; Borsi L; Berndt A; Kosmehl H; Zardi L; Neri D
    Cancer Res; 2003 Jun; 63(12):3202-10. PubMed ID: 12810649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic evaluation of ibuprofen in canine hypovolemic shock.
    Beamer KC; Daly T; Vargish T
    Circ Shock; 1987; 23(1):51-7. PubMed ID: 3690813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.